DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Purchased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. grew its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 9.0% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 494,737 shares of the medical instruments supplier's stock after buying an additional 40,936 shares during the period. Envestnet Asset Management Inc. owned 0.25% of DENTSPLY SIRONA worth $7,391,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Treasurer of the State of North Carolina raised its holdings in DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock worth $1,686,000 after purchasing an additional 560 shares in the last quarter. Quarry LP raised its holdings in DENTSPLY SIRONA by 25.7% during the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares in the last quarter. Federated Hermes Inc. grew its position in DENTSPLY SIRONA by 0.5% during the fourth quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock worth $3,213,000 after buying an additional 915 shares during the period. Covestor Ltd increased its holdings in DENTSPLY SIRONA by 14.9% in the fourth quarter. Covestor Ltd now owns 8,322 shares of the medical instruments supplier's stock valued at $158,000 after buying an additional 1,081 shares in the last quarter. Finally, Colonial Trust Co SC purchased a new position in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY traded down $0.43 during trading on Friday, reaching $16.03. 3,278,545 shares of the company's stock traded hands, compared to its average volume of 2,518,043. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $27.95. The company has a 50 day moving average of $16.04 and a 200-day moving average of $16.19. The stock has a market capitalization of $3.19 billion, a P/E ratio of -3.53, a price-to-earnings-growth ratio of 1.14 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same quarter in the prior year, the firm earned $0.42 EPS. The company's revenue for the quarter was down 7.8% compared to the same quarter last year. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.99%. The ex-dividend date was Friday, June 27th. DENTSPLY SIRONA's payout ratio is -14.10%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on XRAY shares. UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Sunday, July 13th. Barrington Research reiterated an "outperform" rating and issued a $21.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Finally, Piper Sandler dropped their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Ten analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $19.60.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.